UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1063-1068

2015

Link zum Volltext

Verfügbarkeit prüfen

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.558-564

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT

Bone marrow transplantation (Basingstoke), 2021-09, Vol.56 (9), p.2194-2202

2021

Link zum Volltext

Verfügbarkeit prüfen

Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2018-03, Vol.53 (3), p.281-290

2018

Link zum Volltext

Verfügbarkeit prüfen

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2019-11, Vol.54 (11), p.1815-1826

2019

Link zum Volltext

Verfügbarkeit prüfen

A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2755-2762

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Bone marrow transplantation (Basingstoke), 2017-05, Vol.52 (5), p.678-682

2017

Link zum Volltext

Verfügbarkeit prüfen

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g m ) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients

Bone marrow transplantation (Basingstoke), 2006-08, Vol.38 (4), p.275-284

2006

Link zum Volltext

Verfügbarkeit prüfen

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

Bone marrow transplantation (Basingstoke), 2009-02, Vol.43 (4), p.275-291

2009

Link zum Volltext

Verfügbarkeit prüfen

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

Bone marrow transplantation (Basingstoke), 2015-06, Vol.50 (6), p.781-789

2015

Link zum Volltext

Verfügbarkeit prüfen

Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies

Bone marrow transplantation (Basingstoke), 2020-04, Vol.55 (4), p.763-772

2020

Link zum Volltext

Verfügbarkeit prüfen

The EBMT activity survey 2009: trends over the past 5 years

Bone marrow transplantation (Basingstoke), 2011-04, Vol.46 (4), p.485-501

2011

Link zum Volltext

Verfügbarkeit prüfen

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

Bone marrow transplantation (Basingstoke), 2017-06, Vol.52 (6), p.811-817

2017

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

Bone marrow transplantation (Basingstoke), 2016-06, Vol.51 (6), p.786-792

2016

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic stem cell transplantation in Europe 2014: more than 40000 transplants annually

Bone marrow transplantation (Basingstoke), 2016-06, Vol.51 (6), p.786

2016

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of FLT3 in AML: a focus on sorafenib

Bone marrow transplantation (Basingstoke), 2017-03, Vol.52 (3), p.344-351

2017

Link zum Volltext

Verfügbarkeit prüfen

FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study

Bone marrow transplantation (Basingstoke), 2021-01, Vol.56 (1), p.285-288

2021

Link zum Volltext

Verfügbarkeit prüfen

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

Bone marrow transplantation (Basingstoke), 2008-04, Vol.41 (8), p.687-705

2008

Link zum Volltext

Verfügbarkeit prüfen

Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission

Bone marrow transplantation (Basingstoke), 2020-12, Vol.55 (12), p.2244-2253

2020

Link zum Volltext

Verfügbarkeit prüfen

Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects

Bone marrow transplantation (Basingstoke), 2015-12, Vol.50 (12), p.1495-1502

2015

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

Bone marrow transplantation (Basingstoke), 2014-06, Vol.49 (6), p.744-750

2014

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2014-04, Vol.49 (4), p.567-571

2014

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

Bone marrow transplantation (Basingstoke), 2015-04, Vol.50 (4), p.476-482

2015

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic SCT in Europe: data and trends in 2011

Bone marrow transplantation (Basingstoke), 2013-09, Vol.48 (9), p.1161-1167

2013

Link zum Volltext

Verfügbarkeit prüfen

The 47.sup.th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions

Bone marrow transplantation (Basingstoke), 2021-06, Vol.56 (Suppl 1), p.21

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieScientific Reports

Zeitschrift / SerieBone Marrow Transplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(15)

Erscheinungsjahr

n.n

Kollektion

EZB Electronic Journals Library
(48)
Springer Nature - Connect here FIRST to enable access
(48)
Nexis Uni
(45)
Journals@Ovid Complete
(43)
IngentaConnect Journals
(14)

Zeitschrift / Serie

Bone Marrow Transplant
(1)

Menü

Weitere Dienste

Einstellungen

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT

Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantation

Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g m ) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies

The EBMT activity survey 2009: trends over the past 5 years

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

Hematopoietic stem cell transplantation in Europe 2014: more than 40000 transplants annually

Inhibition of FLT3 in AML: a focus on sorafenib

FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission

Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

Hematopoietic SCT in Europe: data and trends in 2011

The 47.sup.th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions

Aktive Filter

Suchergebnisse filtern